ESMO20 YO for YO: highlights on adjuvant CDK4/6 inhibitors in early hormone receptor-positive/HER2-negative breast cancer

por Matikas, A., Lambertini, M.
Publicado 2020

ESMO20 YO for YO: highlights on immune checkpoint blockade for triple-negative breast cancer

por Punie, K., Matikas, A.
Publicado 2020

Avoiding over- and undertreatment in patients with resected node-positive breast cancer with the use of gene expression signatures: are we there yet?

por Matikas, A, Foukakis, T, Swain, S, Bergh, J
Publicado 2019

A multicentre phase II trial of cabazitaxel in patients with advanced non-small-cell lung cancer progressing after docetaxel-based chemotherapy

por Kotsakis, A, Matikas, A, Koinis, F, Kentepozidis, N, Varthalitis, I I, Karavassilis, V, Samantas, Ep, Katsaounis, P, Dermitzaki, E K, Hatzidaki, D, Mavroudis, D, Georgoulias, V
Publicado 2016

Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer

por Matikas, A., Wang, K., Lagoudaki, E., Acs, B., Zerdes, I., Hartman, J., Azavedo, E., Bjöhle, J., Carlsson, L., Einbeigi, Z., Hedenfalk, I., Hellström, M., Lekberg, T., Loman, N., Saracco, A., von Wachenfeldt, A., Rotstein, S., Bergqvist, M., Bergh, J., Hatschek, T., Foukakis, T.
Publicado 2021

Young oncologists’ perspective on the role and future of the clinician-scientist in oncology

por Lim, K.H.J., Westphalen, C.B., Berghoff, A.S., Cardone, C., Connolly, E.A., Güven, D.C., Kfoury, M., Kocakavuk, E., Mandó, P., Mariamidze, E., Matikas, A., Moutafi, M., Oing, C., Pihlak, R., Punie, K., Sánchez-Bayona, R., Sobczuk, P., Starzer, A.M., Tečić Vuger, A., Zhu, H., Cruz-Ordinario, M.V.B., Altuna, S.C., Canário, R., Vuylsteke, P., Banerjee, S., de Azambuja, E., Cervantes, A., Lambertini, M., Mateo, J., Amaral, T.
Publicado 2023